{"id":"https://openalex.org/W2063464585","doi":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","title":"In vitroandin vivoglucuronidation of midazolam in humans","display_name":"In vitroandin vivoglucuronidation of midazolam in humans","alternate_titles":[],"publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W2063464585","doi":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","mag":"2063464585","pmid":"https://pubmed.ncbi.nlm.nih.gov/19371318","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2679108"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.2009.03386.x","doi":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2009.03386.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2063464585"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2009.03386.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108510291","display_name":"Ruth Hyland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ruth Hyland","raw_affiliation_strings":["Pharmacokinetics Dynamics and Metabolism, Pfizer Global R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK. ruth.hyland@pfizer.com","Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics Dynamics and Metabolism, Pfizer Global R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK. ruth.hyland@pfizer.com","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toby Osborne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162608824","display_name":"University of Sussex","ror":"https://ror.org/00ayhx656","country_code":"GB","type":"education","lineage":["https://openalex.org/I162608824"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toby Osborne","raw_affiliation_strings":["Department of Biochemistry, University of Sussex, Brighton and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Sussex, Brighton and","institution_ids":["https://openalex.org/I162608824"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anthony Payne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony Payne","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053557618","display_name":"Sarah Kempshall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Kempshall","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054238060","display_name":"Y. Raj Logan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Raj Logan","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078690613","display_name":"Khaled Ezzeddine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143804889","display_name":"Loughborough University","ror":"https://ror.org/04vg4w365","country_code":"GB","type":"education","lineage":["https://openalex.org/I143804889"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Khaled Ezzeddine","raw_affiliation_strings":["Department of Chemistry, Loughborough University, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Loughborough University, Loughborough, UK","institution_ids":["https://openalex.org/I143804889"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035426293","display_name":"Barry Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barry Jones","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism and Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich,","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5108510291"],"corresponding_institution_ids":["https://openalex.org/I180857899","https://openalex.org/I189718659"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":4.5687,"has_fulltext":true,"cited_by_count":91,"citation_normalized_percentile":{"value":0.95301675,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"67","issue":"4","first_page":"445","last_page":"454"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.9869999885559082},{"id":"https://openalex.org/keywords/n-glucuronidation","display_name":"N-glucuronidation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/ugt1a4","display_name":"UGT1A4","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ugt2b4","display_name":"UGT2B4","score":0.8119999766349792},{"id":"https://openalex.org/keywords/ugt2b7","display_name":"UGT2B7","score":0.9959999918937683},{"id":"https://openalex.org/keywords/1-hydroxymidazolam","display_name":"1'-hydroxymidazolam","score":0.9169999957084656},{"id":"https://openalex.org/keywords/glucuronide-conjugates","display_name":"glucuronide conjugates","score":0.6499999761581421},{"id":"https://openalex.org/keywords/in-vivo-drug-metabolism","display_name":"in vivo drug metabolism","score":0.5460000038146973},{"id":"https://openalex.org/keywords/enzyme-kinetics","display_name":"enzyme kinetics","score":0.5590000152587891},{"id":"https://openalex.org/keywords/substrate-inhibition","display_name":"substrate inhibition","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C2779907587","wikidata":"https://www.wikidata.org/wiki/Q14901439","display_name":"Glucuronidation","level":4,"score":0.9457437992095947},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.7748111486434937},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7717610597610474},{"id":"https://openalex.org/C2778000748","wikidata":"https://www.wikidata.org/wiki/Q423071","display_name":"Midazolam","level":3,"score":0.7255668044090271},{"id":"https://openalex.org/C2779186261","wikidata":"https://www.wikidata.org/wiki/Q137786","display_name":"Glucuronide","level":3,"score":0.7247878909111023},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6133037209510803},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.5829374194145203},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5080819129943848},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.48930737376213074},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.4694506525993347},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.44585302472114563},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23270922899246216},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.06080973148345947},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020719","descriptor_name":"Glucuronides","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D020719","descriptor_name":"Glucuronides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020719","descriptor_name":"Glucuronides","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.2009.03386.x","doi":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2009.03386.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2679108","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2679108/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:19371318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19371318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.2009.03386.x","doi":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2009.03386.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2009.03386.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2063464585.pdf","grobid_xml":"https://content.openalex.org/works/W2063464585.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W94870893","https://openalex.org/W1958017720","https://openalex.org/W1965595062","https://openalex.org/W1971559706","https://openalex.org/W1986618988","https://openalex.org/W2004292348","https://openalex.org/W2004911611","https://openalex.org/W2008440205","https://openalex.org/W2009170744","https://openalex.org/W2019261370","https://openalex.org/W2022867918","https://openalex.org/W2030358514","https://openalex.org/W2031971349","https://openalex.org/W2042602590","https://openalex.org/W2042985281","https://openalex.org/W2049385501","https://openalex.org/W2052521989","https://openalex.org/W2070140634","https://openalex.org/W2102688834","https://openalex.org/W2108342553","https://openalex.org/W2112918810","https://openalex.org/W2133270655","https://openalex.org/W2139177217","https://openalex.org/W2147753513","https://openalex.org/W2150274048","https://openalex.org/W2153001007","https://openalex.org/W2157501385","https://openalex.org/W2161060771","https://openalex.org/W2161976213","https://openalex.org/W2203399572","https://openalex.org/W2315223187"],"related_works":["https://openalex.org/W371816603","https://openalex.org/W2147753513","https://openalex.org/W2157913832","https://openalex.org/W6977208137","https://openalex.org/W2942409855","https://openalex.org/W1971636171","https://openalex.org/W2363938740","https://openalex.org/W2307048084"],"abstract_inverted_index":{"WHAT":[0,44],"IS":[1],"ALREADY":[2],"KNOWN":[3],"ABOUT":[4],"THIS":[5,45],"SUBJECT":[6],"\u2022":[7,22,31,48,70,82],"Midazolam":[8,23],"is":[9,13,24,34,105,302],"extensively":[10],"metabolized":[11],"and":[12,38,40,100,155,193,208,258,285,292,299,312],"eliminated":[14],"in":[15,55,95,113,191,235,283],"urine":[16,181,237],"predominantly":[17],"as":[18,109,248],"conjugates":[19],"of":[20,50,66,72,79,90,93,98,120,134,142,148,186,219,229,241,251,296,309,321],"1\u2032\u2010hydroxymidazolam.":[21],"known":[25],"to":[26,138,212,224,267],"undergo":[27],"N\u2010glucuronidationin":[28],"vitroby":[29],"UGT1A4.":[30,43],"In":[32],"vitro1\u2032\u2010hydroxymidazolam":[33],"O\u2010glucuronidated":[35],"by":[36,42],"UGT2B4":[37],"UGT2B7,":[39],"N\u2010glucuronidated":[41],"STUDY":[46],"ADDS":[47],"N\u2010glucuronide":[49,149,221],"midazolam":[51,99,205,220],"has":[52,74,122,316],"been":[53,75,123,317],"quantified":[54],"human":[56,126,180],"urine,":[57],"indicating":[58],"for":[59,239,333],"the":[60,91,96,187,227,230,236,242,249,313],"first":[61],"time":[62],"that":[63,78],"this":[64,135,143],"route":[65],"metabolism":[67,97,311],"occursin":[68,323],"vivo.":[69,324],"Metabolism":[71],"4\u2010hydroxymidazolam":[73],"compared":[76],"with":[77,203,290],"1\u2032\u2010hydroxymidazolamin":[80],"vitro.":[81],"This":[83],"study":[84,136],"provides":[85],"further":[86],"evidence,in":[87],"vitroandin":[88],"vivo,":[89,233],"importance":[92],"N\u2010glucuronidation":[94,295,320],"its":[101],"metabolites.":[102],"AIMSMidazolam":[103],"(MDZ)":[104],"a":[106,110,259],"benzodiazepine":[107],"used":[108],"CYP3A4":[111],"probe":[112],"clinical":[114],"andin":[115],"vitrostudies.":[116],"A":[117],"glucuronide":[118],"metabolite":[119,176],"MDZ":[121,298,301,310,322],"identifiedin":[124],"vitroin":[125],"liver":[127],"microsome":[128],"(HLM)":[129],"incubations.":[130],"The":[131,160,175,253],"primary":[132],"aim":[133],"was":[137,150,162,177,189,265],"understand":[139],"thein":[140],"vivorelevance":[141],"pathway.":[144],"METHODSAn":[145],"authentic":[146],"standard":[147,223],"generated":[151],"from":[152],"microsomal":[153],"incubations":[154,289],"isolated":[156],"using":[157,164,327],"solid\u2010phase":[158],"extraction.":[159],"structure":[161],"confirmed":[163,217,246],"proton":[165],"nuclear":[166],"magnetic":[167],"resonance":[168],"(NMR)":[169],"and1H\u201013C":[170],"long":[171],"range":[172],"correlation":[173],"experiments.":[174],"quantifiedin":[178],"vivoin":[179],"samples.":[182],"Enzyme":[183],"kinetic":[184],"behaviour":[185],"pathway":[188,254],"investigated":[190],"HLM":[192,284,291],"recombinant":[194],"UGT":[195],"(rUGT)":[196],"enzymes.":[197],"Additionally,":[198],"preliminary":[199],"experiments":[200],"were":[201],"performed":[202],"1\u2032\u2010OH":[204,297],"(1\u2032\u2010OH":[206],"MDZ)":[207,211],"4\u2010OH\u2010midazolam":[209],"(4\u2010OH":[210],"investigate":[213],"N\u2010glucuronidation.":[214],"RESULTSNMR":[215],"data":[216],"conjugation":[218],"(MDZG)":[222],"be":[225],"on":[226],"\u03b1\u2010nitrogen":[228],"imidazole":[231],"ring.In":[232],"MDZG":[234],"accounted":[238],"1\u20132%":[240],"administered":[243],"dose.In":[244],"vitroincubations":[245],"UGT1A4":[247,334],"enzyme":[250],"interest.":[252],"exhibited":[255],"atypical":[256],"kinetics":[257],"substrate":[260],"inhibitory":[261],"cooperative":[262],"binding":[263],"model":[264],"applied":[266],"determineKm(46":[268],"\u00b5M,":[269,280],"64":[270],"\u00b5M),Vmax(445":[271],"pmol":[272,276],"min\u22121":[273,277],"mg\u22121,":[274],"427":[275],"mg\u22121)":[278],"andKi(58":[279],"79":[281],"\u00b5M)":[282],"rUGT1A4,":[286],"respectively.":[287],"From":[288],"rUGT":[293],"enzymes,":[294],"4\u2010OH":[300],"also":[303],"inferred.":[304],"CONCLUSIONSA":[305],"more":[306],"complete":[307],"picture":[308],"enzymes":[314],"involved":[315],"elucidated.":[318],"Direct":[319],"Pharmacokinetic":[325],"modelling":[326],"Simcyp\u2122":[328],"illustrates":[329],"an":[330],"increased":[331],"role":[332],"under":[335],"CYP3A":[336],"inhibited":[337],"conditions.":[338]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2063464585","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
